JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M100609200 on July 5, 2001

J. Biol. Chem., Vol. 276, Issue 36, 34035-34040, September 7, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/36/34035    most recent
M100609200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Friebel, A.
Right arrow Articles by Hardt, W.-D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Friebel, A.
Right arrow Articles by Hardt, W.-D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

SopE and SopE2 from Salmonella typhimurium Activate Different Sets of RhoGTPases of the Host Cell*

Andrea FriebelDagger , Heiko IlchmannDagger , Martin AepfelbacherDagger , Kristin EhrbarDagger , Werner Machleidt§, and Wolf-Dietrich HardtDagger

From the Dagger  Max von Pettenkofer-Institut, Ludwig Maximilians Universität, Pettenkoferstrasse 9a, 80336 München and the § Adolf-Butenandt-Institut für Physiologische Chemie, Physikalische Biochemie und Zellbiologie, Ludwig-Maximilians-Universität München, Schillerstrasse 42, D-80336 München, Germany

Received for publication, January 23, 2001, and in revised form, June 1, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The bacterial enteropathogen Salmonella typhimurium employs a specialized type III secretion system to inject toxins into host cells, which trigger signaling cascades leading to cell death in macrophages, secretion of pro-inflammatory cytokines, or rearrangements of the host cell cytoskeleton and thus to bacterial invasion. Two of the injected toxins, SopE and the 69% identical protein SopE2, are highly efficient guanine nucleotide exchange factors for the RhoGTPase Cdc42 of the host cell. However, it has been a puzzle why S. typhimurium might employ two toxins with redundant function. We hypothesized that SopE and SopE2 might have different specificities for certain host cellular RhoGTPases. In vitro guanine nucleotide exchange assays and surface plasmon resonance measurements revealed that SopE is an efficient guanine nucleotide exchange factor for Cdc42 and Rac1, whereas SopE2 was interacting efficiently only with Cdc42, but not with Rac1. Affinity precipitation of Cdc42·GTP and Rac1·GTP from lysates and characteristic cytoskeletal rearrangements of infected tissue culture cells confirmed that SopE is highly efficient at activating Cdc42 and Rac1 in vivo, whereas SopE2 was efficiently activating Cdc42, but not Rac1. We conclude that the translocated effector proteins SopE and SopE2 allow S. typhimurium to specifically activate different sets of RhoGTPase signaling cascades.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The RhoGTPase subfamily of the Ras superfamily of small GTP-binding proteins comprises more than 10 different proteins (1). They act as molecular switches and cycle between GDP-bound (inactive) and GTP-bound (active) conformations (2). Activation and inactivation of RhoGTPases is controlled by guanine nucleotide exchange factors (GEFs),1 GTPase-activating enzymes, and guanine dissociation inhibitors (3, 4). The eukaryotic GEFs for Rho-GTPases share two common sequence motives, the DH (Dbl homology) and the PH (pleckstrin homology) domains, which are responsible for targeting, binding the RhoGTPases, and catalysis of RhoGTPase·GDP right-arrow RhoGTPase·GTP exchange (5). Only the active GTP-bound RhoGTPases can interact with downstream elements of signal transduction cascades mediating the cellular responses. GTPases of the Rho subfamily are central switches in the signaling cascades regulating motility, cellular adhesion, cell shape, cytokinesis, cell contraction, and gene expression (6, 7). Each of the RhoGTPases can regulate a specific set of downstream signaling cascades, leading to activation of specific cellular functions (4). For example, in Swiss 3T3 cells, activation of Cdc42 leads to the formation of filopodia, activation of Rac1 induces formation of lamellipodia, and activation of RhoA leads to the formation of stress fibers and focal adhesions (8-11). Thus, selective activation of specific RhoGTPases leads to specific cellular responses.

Invasion of the Gram-negative bacterial enteropathogen Salmonella typhimurium (Salmonella enterica subspecies I serovar Typhimurium) into non-phagocytic mammalian cells is studied as a model system for the "trigger mechanism" of bacterial invasion (12). For triggering invasion, S. typhimurium employs the specialized type III secretion system encoded in "Salmonella pathogenicity island I" (SPI1) to inject/translocate a set of at least nine different bacterial toxins (called "effector proteins") into host cells (13-22). Inside the host cell, the effector proteins activate signaling cascades leading to a variety of responses including cytoskeletal rearrangements and bacterial internalization/invasion (12).

It has been shown that Cdc42 is a key element in the Salmonella-induced signaling cascades leading to transcriptional activation and bacterial invasion: disruption of Cdc42 signaling by transfection with dominant negative Cdc42N17 alleles interferes with bacterial invasion and activation of c-Jun kinase and p21-activated kinase (PAK) signaling (23-25). Rac1 plays a less prominent role, and disruption of Rac1 signaling merely leads to reduced S. typhimurium invasion rates, whereas inhibition of RhoA signaling does not affect invasion at all (23). This suggests that the translocated effector proteins of S. typhimurium may preferentially address certain RhoGTPase signaling pathways.

Recent work has demonstrated that S. typhimurium (strain SL1344) relies mainly on a set of three translocated effector proteins to trigger invasion. A triple mutant S. typhimurium strain lacking SopB, SopE, and SopE2 is non-invasive, even though the SPI1 type III secretion system is still fully functional (22, 24, 26-30). SopB has phosphatidyl inositol phosphatase activity and a sopB- mutant is less invasive than wild type S. typhimurium (28, 31). Until now, however, the molecular mechanism explaining the role of SopB in triggering invasion has been unclear.

SopE and SopE2 of S. typhimurium are 69% identical (21, 22, 27). Besides the lack of any recognizable sequence similarity to proteins with DH or PH domains, both proteins are highly efficient GEFs for Cdc42 in vitro (22, 24, 32). In fact, the catalytic parameters of SopE-mediated guanine nucleotide exchange of Cdc42 are similar to those reported for the active domains of eukaryotic GEFs for members of the Ras superfamily (32). The specificity of SopE and SopE2 for other GTPases of the Rho subfamily has not been studied in detail. If both bacterial virulence factors had different preferences for different RhoGTPases, SopE and SopE2 might provide S. typhimurium with a means to differentially activate specific signaling pathways inside the host cell.

In the present study we have analyzed the specificity of SopE and SopE2 for the RhoGTPases Cdc42 and Rac1. Biochemical analyses of purified recombinant proteins and analysis of RhoGTPase activity in infected tissue culture cells revealed that SopE is an efficient activator for both Cdc42 and Rac1 in vitro and in vivo. In contrast, SopE2 efficiently activates Cdc42, but not Rac1. This demonstrates for the first time that expression of two homologous translocated effectors with GEF activity for RhoGTPases allows S. typhimurium to differentially activate specific signaling pathways within host cells.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Bacterial Strains-- All S. typhimurium strains used in this study have been described (26) and are isogenic derivatives of the virulent wild-type strain SL1344 (33). M516 (SL1344, Delta sopB, sopE::aphT, sopE2::tetr) lacks the three major effector proteins necessary for tissue culture cell invasion (26). Transformation of M516 with pM136 (pBAD24, which expresses SopE1-240-M45 under the control of the native sopE promotor; Ref. 22) or with pM226 (pBAD24, which expresses SopE21-240-M45 under the control of the native sopE2 promotor; Ref. 22) complements the invasion defect. For tissue culture cell infection experiments, the bacteria were grown in high salt media as described (22).

Preparation of Recombinant Proteins-- Preparation of recombinant proteins was performed essentially as described (32, 34). Briefly, all proteins used in this study were overexpressed as GST fusion proteins, recovered from bacterial extracts by binding to glutathione-Sepharose 4B (Amersham Pharmacia Biotech) and either eluted with 20 mM glutathione (GST, GST-SopE78-240, GST-SopE269-240, GST-Cdc42Hs1-192, and GST-Rac11-191) or cleaved off the column by digestion with thrombin protease (SopE78-240 and SopE269-240, Cdc42Hs1-192 and Ha-Ras) or with factor Xa (Rac11-191). Proteins were concentrated by ultrafiltration (Mr cut-off 8000), snap-frozen in liquid nitrogen, and stored at -80 °C.

Due to design of the expression vectors, the proteins carry the following additional amino acids. GST-SopE78-240 carries PGISGGGGGILEFEM between the thrombin cleavage site and Leu-78 of SopE; GST-SopE269-240 carries PGISGGGGGIL between the thrombin cleavage site and Gly-69 of SopE2; SopE78-240 carries the additional N-terminal amino acids GSPGISGGGGGILEFEM; SopE269-240 carries the additional N-terminal amino acids GSPGISGGGGGIL; GST- Rac11-191 carries GIDPGAT between the factor Xa recognition site and Met-1 of Rac1; Rac11-191 carries the N-terminal amino acids GIDPGAT; Ha-Ras carries the additional N-terminal amino acids GS; GST-Cdc42Hs1-192 carries RRASVGSKIISA between the thrombin recognition site and Met-1 of Cdc42. Cdc42Hs1-192 carries the N-terminal amino acids GSRRASVGSKIISA.

The expression vector for the GST fusion protein with the Rac1 and Cdc42 binding region (aa 56-272) of human PAK1B was generously provided by E. Sander and J. G. Collard (35), and purification of the protein bound to glutathione-Sepharose beads was performed as described (35).

Preparation of mGDP·Cdc42Hs1-192 Complex-- To remove the associated GDP, GST-Cdc42Hs1-192 bound to a glutathione-Sepharose 4B column was washed with 10 ml of buffer D (50 mM Tris-HCl, pH 7.6, 100 mM NaCl, 2 mM EDTA, 2 mM DTT). Afterward, beads were incubated as a batch in the presence of a 2.5-fold molar excess of fluorescent mGDP (Molecular Probes, Netherlands) for 10 min at 22 °C in buffer D. After addition of excess MgCl2, mGDP·Cdc42Hs1-192 was cleaved off the column material using thrombin (Amersham Pharmacia Biotech) in buffer A (4 °C; overnight) and unbound mGDP was removed by gel filtration chromatography. Fractions containing the mGDP·Cdc42Hs1-192 complex were identified by fluorescence spectroscopy, pooled, concentrated by ultrafiltration (Millipore Ultrafree-15, Mr cut-off 8000), snap-frozen, and stored at -80 °C.

Preparation of mGDP·Rac11-191 Complex-- For preparation of mGDP·Rac11-191, we devised a new method based on the high stability of the SopE·Rac1 complex (32). 2 mg of GST-SopE78-240 was bound to a glutathione-Sepharose 4B column. Rac11-191 (in buffer A: 50 mM Tris-HCl, pH 7.6, 100 mM NaCl, 5 mM MgCl2, 2 mM DTT) was applied to the column, and unbound Rac11-191 was removed by washing with 10 ml of buffer A. The bound Rac11-191 was eluted as mGDP·Rac11-191 complex using buffer A (20 °C) supplemented with 200 µM mGDP and purified and concentrated as described above for mGDP·Cdc42Hs1-192.

Filter Binding Assays-- Filter binding assays were performed in buffer B (50 mM Tris-HCl, pH 7.6, 50 mM NaCl, 5 mM MgCl2, 5 mM DTT) as described (22, 32).

Surface Plasmon Resonance-- Association and dissociation reactions involving GST-Cdc42Hs1-192, GST-Rac11-191, SopE78-240, and SopE269-240 were analyzed in buffer E (10 mM HEPES/NaOH, pH 7.3, 150 mM NaCl, 5 mM MgCl2, 0.005% Igepal CA-630 (Sigma)) using surface plasmon resonance (BIAcore 2000 system) as described recently (32).

Fluorescence Spectrometry-- Fluorescence measurements were performed at 20 °C in buffer F (40 mM HEPES/NaOH, pH 7.3, 100 mM NaCl, 5 mM MgCl2) on an Aminco Bowman series 2 fluorescence spectrometer (excitation: 366 nm; emission: 440 nm). Increasing concentrations of either mGDP·Rac11-191 or mGDP·Cdc42Hs1-192 were premixed with SopE78-240 or SopE269-240 (final concentrations: 25 nM). Reactions were started by addition of unlabeled GDP (1 mM final concentration), and dissociation of mGDP was recorded as decreased fluorescence at 440 nm.

GST-PAK-Cdc42/Rac Interactive Binding Domain Affinity Purification Assay-- To measure the amounts of Cdc42·GTP and Rac1·GTP in infected tissue culture cells, we performed affinity purification assays as described (35). Briefly, confluent COS7 cells grown in Dulbecco's modified Eagle's medium (5% fetal bovine serum) were infected with S. typhimurium at a multiplicity of infection of 50 bacteria/cell. Cells were washed with cold PBS and lysed in 1 ml of GST-fish buffer (10% glycerol, 50 mM Tris-HCl, pH 7.6, 100 mM NaCl, 1% Igepal CA-630, 2 mM MgCl2 supplemented with "complete" protease inhibitor mixture (Roche Molecular Biochemicals)), lysates were cleared by centrifugation (4000 × g; 4 °C), and the activated Rac1/Cdc42 was recovered by binding to immobilized GST-PAK-cdc42/Rac interactive binding domain fusion protein (see above; 30 min, 4 °C). The beads were washed, and the amount of activated Cdc42·GTP and Rac1·GTP was determined by Western blot analysis using mouse-alpha -Rac1 (1:2500 in PBS, 5% nonfat milk; Upstate Biotechnology, Inc.) or mouse-alpha -Cdc42 (1:500, Transduction Laboratories) antibodies. SopE1-240-M45 and SopE21-240-M45 proteins were detected using mouse-alpha M45 antibody (1:100 in PBS, 5% nonfat milk; Ref. 36), a secondary horseradish peroxidase-conjugated alpha -mouse antibody (1:12000; Dianova) and the ECL Plus detection kit, as recommended by the manufacturer (Amersham Pharmacia Biotech).

Actin Cytoskeletal Rearrangements in Human Umbilical Vein Endothelial Cell (HUVEC) Tissue Culture-- HUVECs were grown to confluence in endothelial cell growth medium (Promo Cell, endothelial cell growth supplement/H, 10% FCS) on gelatin-coated plastic coverslips (Thermanox, Nalge Nunc International) as described previously (37). The culture medium was replaced with serum-free endothelial cell growth medium, and cells were infected with S. typhimurium (multiplicity of infection = 50) for 40 min, washed, fixed with PBS and 4% paraformaldehyde, permeabilized with PBS and 0.1% Triton X-100, and stained with rhodamine-phalloidin (Molecular Probes, 1:20 in PBS, 3% BSA). Bacteria were stained with alpha -Salmonella O-1,4,5,12(8) antiserum (Difco, 1:400 in PBS, 3% BSA) and a secondary alpha -rabbit fluorescein isothiocyanate conjugate (Sigma, 1:250 in PBS, 3% BSA). Coverslips were mounted and analyzed by fluorescence microscopy. Cells with obvious rearrangments in the actin cytoskeleton (~35% of all cells) were evaluated and classified based on their cytoskeletal structure.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

SopE and SopE2 Display Differential Specificities for Cdc42Hs and Rac1-- Previous work had shown that SopE and SopE2 are efficient guanine nucleotide exchange factors for Cdc42 (22, 32). Guanine nucleotide exchange factor activity for other RhoGTPases has not been studied in detail. Here, we have compared the GEF-activity of SopE78-240 and SopE269-240 on Rac11-191 and Cdc42Hs1-192. Cdc42Hs1-192, Rac11-191, or Ha-Ras was loaded with [3H]GDP, and we determined the rates of SopE78-240- or SopE269-240-mediated [3H]GDP release using filter binding assays (Fig. 1; see "Materials and Methods"). In line with earlier results (22), 1 µM SopE78-240 and SopE269-240 catalyzed fast [3H]GDP release from Cdc42Hs1-192 (Fig. 1, a () and d (×)). In contrast, [3H]GDP release from Rac11-191 was much faster in the presence of SopE78-240 (Fig. 1b, ) than in the presence of 1 µM SopE269-240 (Fig. 1e, ×). Therefore, SopE78-240 is a highly efficient GEF for Cdc42Hs1-192 and Rac11-191, whereas SopE269-240 acts equally efficient on Cdc42Hs1-192, but is much less active on Rac11-191 in vitro.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 1.   Rates of guanine nucleotide exchange catalyzed by SopE and SopE2. [3H]GDP release from Cdc42Hs1-192·[3H]GDP (panels a and d), Rac11-191·[3H]GDP (panels b and e), and Ha-Ras·[3H]GDP (panels c and f) in the presence of 1 mM GDP and 1 µM SopE78-240 (), 1 µM SopE269-240 (×), 10 mM EDTA (triangle ), or 1 µM GST (black-diamond ) was analyzed using a filter binding assay. The data were acquired in three independent experiments.

Association/Dissociation Kinetics of the Complexes between SopE, SopE2, Rac1, and Cdc42Hs-- To analyze the binding specificity of SopE and SopE2, we have measured the kinetics of formation and dissociation of the complexes between Cdc42 (or Rac1) and SopE2 (or SopE) using surface plasmon resonance. This technique allows one to study binding/dissociation kinetics by measuring the change in mass on the surface of a sensor chip.

GST-Cdc42Hs1-192 or GST-Rac11-191 fusion protein (or GST as a control) was bound to a sensor chip, and we measured the kinetics of binding of SopE78-240 (or SopE269-240; 100 nM; Fig. 2a). The observed rates of complex formation between GST-Cdc42Hs1-192, GST-Rac11-191, SopE78-240, and SopE269-240 were dependent on the concentration of the RhoGTPase applied (Fig. 2b; data not shown). From the binding curves, we calculated the kinetic constants for complex formation (ka) assuming simple one-step bimolecular association reactions:SopE78-240 binds with similar kinetics to GST-Cdc42Hs1-192 and to GST-Rac11-191 (Table I). In contrast, the association rate constant for formation of the GST-Cdc42Hs1-192·SopE269-240 complex is 7-fold higher than for the GST-Rac11-191·SopE269-240 complex.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 2.   Surface plasmon resonance measurement of the SopE/SopE2 interaction with Cdc42Hs or Rac1. a, binding kinetics of SopE78-240 (100 nM) and SopE269-240 (100 nM) to GST-Cdc42Hs1-192 and GST-Rac11-191. b, concentration dependence of the rates of binding of SopE269-240 to GST-Cdc42Hs1-192 or to GST-Rac11-191. After washing with buffer E (0-90 s), we applied SopE269-240 in buffer E at the indicated concentrations. The sensorgrams were corrected to show the specific signal changes. w, start of washing with buffer E.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Surface plasmon resonance measurement of the association/dissociation of SopE/SopE2 complexes with GST-Cdc42/GST-Rac1

We have also analyzed the dissociation of the complexes (Table I). However, in the absence of GDP, dissociation was slow and the dissociation rate constants are prone to experimental error and should be regarded as rough estimates. The GST-Cdc42Hs1-192·SopE78-240 complex and the GSTRac11-191·SopE78-240 complex are roughly equally stable. In contrast, dissociation of the GST-Rac11-191·SopE269-240 complex is 6-fold faster than dissociation of the GST-Cdc42Hs1-192·SopE269-240 complex (Table I). Overall, SopE78-240 binds with very similar equilibrium binding constants (KD = koff/ka) to GST-Cdc42Hs1-192 and to GST-Rac11-191 (KD = 3.1 × 10-10 M), whereas equilibrium binding of SopE269-240 to GST-Cdc42Hs1-192 is 40-fold stronger than equilibrium binding to GST-Rac11-191 (Table I).

In line with previous results for the GST-SopE78-240·Cdc42Delta C complex (32), dissociation of all complexes between GST-RhoGTPases and SopE78-240 or SopE269-240 was accelerated more than 1000-fold in the presence of 20 µM GDP and the dissociation reactions were completed in less than 5 s (data not shown). Identical dissociation curves were obtained when we employed 20 µM GTP (data not shown). However, the dissociation kinetics in the presence of guanine nucleotides were too fast to allow an accurate analysis in order to detect differences between the dissociation rates of the complexes with GST-Cdc42Hs1-192 and GST-Rac11-191.

Multiple Turnover Kinetics of SopE- and SopE2-mediated Nucleotide Exchange-- We have also analyzed the SopE78-240- and SopE269-240-mediated nucleotide exchange in multiple turnover kinetic experiments using O-(N-methylanthraniloyl-GDP (mGDP), a fluorescent GDP derivative. The fluorescence of mGDP bound to Cdc42 is 4-fold higher than the fluorescence of unbound mGDP (32, 38, 39). The kinetics and concentration dependence of mGDP dissociation from Cdc42Hs1-192·mGDP or Rac11-191·mGDP was followed by fluorescence spectrometry (Fig. 3). In the SopE78-240-mediated nucleotide exchange reactions, Cdc42Hs1-192·mGDP nucleotide dissociation rate constants (v) reached a plateau at 20-40 µM and the Michaelis-Menten parameters (kcat = 5 ± 1 s-1 and Km = 6 ± 2 µM; Table II) were in the same order of magnitude as those reported for SopE78-240-mediated nucleotide exchange on Cdc42V12·mGDP (kcat = 0.95 ± 0.06 s-1 and Km = 4.5 ± 0.9 µM; Ref. 32). It is unclear whether the slight differences might be attributable to effects of the G12V mutation of Cdc42 used in the earlier study (32). SopE269-240 is an even more efficient GEF for Cdc42Hs1-192 than SopE78-240 (Table II).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 3.   Multiple turnover kinetics of guanine nucleotide exchange by SopE or SopE2. Release of mGDP from Rac11-191·mGDP (1-45 µM) or Cdc42Hs1-192·mGDP (1-60 µM) was analyzed in the presence of 1 mM GDP and 25 nM SopE78-240 or SopE269-240 using fluorescence spectrometry (excitation wavelength = 366 nm; emission wavelength = 440 nm). The curves were fitted assuming a simple dissociation mechanism and the resulting rates (kobs. = [pmol of mGDP released]/[pmol of Sop protein] × s-1) were plotted as a function of the concentrations of Rac11-191·mGDP () or Cdc42Hs1-192·mGDP (diamond ).

                              
View this table:
[in this window]
[in a new window]
 
Table II
Multiple turnover measurements of SopE/SopE2-mediated nucleotide exchange

Neither with SopE78-240 nor with SopE269-240 did the observed nucleotide dissociation rate constants (v) of Rac11-191·mGDP reach a plateau at concentrations up to 50 µM Rac11-191·mGDP; Fig. 3, a and b). Therefore, we could only estimate the catalytic efficiency of SopE78-240 and SopE269-240 from the slopes of the linear plots shown in Fig. 3 (Table II). This indicates that the catalytic efficiency of SopE269-240 (kobs/[Rac11-191·mGDP]) is about 6-fold lower than the catalytic efficiency of SopE78-240.

Affinity Precipitation Assays to Determine Substrate Specificities of SopE and SopE2 in Vivo-- The biochemical analyses presented above show that SopE is an efficient GEF for Rac1 and Cdc42 whereas SopE2 is an efficient GEF for Cdc42 but not for Rac1. It was of interest to also analyze this specificity in vivo. The levels of GTP-bound Rac1 and Cdc42 in tissue culture cells can be analyzed directly in an affinity precipitation assay (35, 40). This assay is based on the ability of the Cdc42/Rac1-binding domain (CD; aa 56-272) of PAK-1 to specifically bind to activated Cdc42·GTP and Rac1·GTP, but not to inactive Cdc42·GDP or Rac1·GDP (35).

For the analysis of RhoGTPase activation by SopE and SopE2 during the course of an infection, we have employed the S. typhimurium SL1344 mutant M516 (sopE::aphT; sopE2::pM218; Delta sopB; Ref. 26), which lacks the three major effector proteins necessary for host cell invasion (26). This strain has a fully functional SPI1 type III secretion system (26) but it is unable to activate Cdc42- or Rac1-signaling (see Fig. 4). To analyze the in vivo specificity of SopE and SopE2, we infected COS7 tissue culture cells for 40 min with the plasmidless control S. typhimurium strain M516 or with M516 complemented with expression vectors for epitope-tagged SopE1-240-M45 (pM136) or SopE21-240-M45 (pM226; Ref. 22). COS7 cell lysates were subsequently analyzed using the GST-PAK-CD affinity precipitation assay (see "Materials and Methods"). M516 complemented with pM136 (SopE1-240-M45) was able to efficiently activate Cdc42 and Rac1 (Fig. 4, lanes 2a and 2b). In contrast, M516 complemented with pM226 (SopE21-240-M45) only activated Cdc42 but not Rac1 (Fig. 4, lanes 3a and 3b). Control experiments verified that the observed differences were not attributable to different amounts of Rac1 or Sop-proteins present in the lysates (Fig. 4, lanes 2c, 3c, 1d, 2d, and 3d). In conclusion, these are in line with the results from the biochemical analyses and show that SopE2 has the capacity to specifically activate Cdc42 signaling in vivo, whereas SopE activates both Rac1 and Cdc42.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 4.   Affinity precipitation assay to measure activation of host cellular Cdc42 and Rac1 by translocated SopE and SopE2. COS7 cells were infected for 40 min with M516 (lanes 1a-1d), M516 complemented with pM136 (SopEM45; lanes 2a-2d), or M516 complemented with pM226 (SopE2M45; lanes 3a-3d). Rac1·GTP and Cdc42·GTP present in the COS7 lysates was affinity-precipitated using GST-PAK-CD beads (see "Materials and Methods"), and quantification of Rac1·GTP and Cdc42·GTP was performed by Western blot analyses using specific mouse alpha -Cdc42 (lane a) or mouse alpha -Rac1 (lane b) antibodies. Lane c, relative amounts of Sop proteins (or Rac1; lane d) present in the lysates detected by Western blot using a specific mouse alpha -M45 (lane c) or a mouse alpha -Rac1 (lane d) antibody. Lanes 4a-4d, positive control. Rac1 and Cdc42 in lysate were activated by loading with GTPgamma S. Lanes 5a-5d, negative control. Rac1 and Cdc42 in lysate was inactivated by loading with GDP. The assay shown is representative for the five independent experiments performed.

SopE and SopE2 Have Different Effects on the Actin Cytoskeleton of HUVECs-- In mammalian cells specific activation of Rho, Rac, and Cdc42 leads to characteristic rearrangements of the actin cytoskeleton. Usually, activation of Cdc42 is associated with the formation of filopodia and activation of Rac1 with formation of lamellipodia ("ruffles"; Refs. 9-11). Therefore, the differential signaling capacity of SopE and SopE2 might lead to different cytoskeletal rearrangements in infected tissue culture cells. In HUVECs, activation of Cdc42 and Rac1 induces formation of filopodia and lamellipodia, respectively (37, 41). Therefore, we have infected HUVECs for 40 min with S. typhimurium strain M516 or with M516 complemented with pM136 (SopE1-240-M45) or with pM226 (SopE21-240-M45). M516 did not induce actin cytoskeletal rearrangements (Fig. 5a). In contrast, M516 complemented with pM136 (SopE1-240-M45) induced the formation of lamellipodia. Infection with M516 complemented with pM226 (SopE21-240-M45) induced formation of filopodia, whereas only a minority of infected cells formed lamellipodia (Fig. 5, a and b). The small number of cells forming lamellipodia (Fig. 5b; M516 + pM226) might be attributable to indirect activation of Rac1 by activated Cdc42 (11). In conclusion, these data are in line with our observation that SopE can efficiently activate Rac1 (and Cdc42) signaling, whereas SopE2 activates Cdc42 but not Rac1 in vivo.


View larger version (64K):
[in this window]
[in a new window]
 
Fig. 5.   SopE/SopE2-induced rearrangements in the HUVEC actin cytoskeleton. a, HUVECs were infected for 40 min with the indicated S. typhimurium strains. Cells were fixed, f-actin was stained with rhodamine-phalloidin (red), and bacteria were stained with a polyclonal alpha -Salmonella antiserum and a secondary alpha -rabbit fluorescein isothiocyanate antibody (green; see "Materials and Methods"). b, quantitative analysis of the SopE/SopE2-induced cytoskeletal rearrangements. Cells with altered actin cytoskeletal morphology (~35% of all cells) were classified based on their morphological features: profound membrane ruffling (i.e. a, panel 2), weak filopodia formation (<20 filopodia/cell), pronounced filopodia formation (>20 filopodia/cell; i.e. a, panel 3). For each S. typhimurium strain, at least 100 cells with altered actin cytoskeletal morphology were evaluated in three independent experiments (experimental error: ±10%). *, no cytoskeletal rearrangements observed.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

It is well established that the translocated S. typhimurium protein SopE acts as an efficient GEF for host cellular Rho-GTPases both in vitro and in vivo (24, 32). This was of special interest, since SopE does not share any recognizable sequence similarity to eukaryotic GEFs or any other known proteins. Recently, it was discovered that S. typhimurium translocates an additional, 69% identical effector protein named SopE2 into host cells (21, 22). SopE2 is also capable of activating Rho-GTPase signaling cascades leading to cytoskeletal rearrangements and bacterial entry (22). Why does S. typhimurium translocate two structurally and functionally similar effector proteins into host cells? We hypothesized that differences in the specificity of SopE and SopE2 for certain RhoGTPases might be one possible explanation. As activation of different RhoGTPases leads to specific changes in key cellular functions (i.e. actin cytoskeletal rearrangements, activation of transcription factors; Ref. 4), this might enable S. typhimurium to precisely manipulate host cell physiology. Therefore, we have analyzed in the present study the specificity of SopE and SopE2 for Cdc42 and Rac1. Indeed, we found SopE is a potent GEF for Cdc42 and for Rac1 both in vitro and in vivo, whereas SopE2 is much more active on Cdc42 than on Rac1. 1) In the absence of free guanine nucleotide, the equilibrium binding of SopE2 to Cdc42 is ~40-fold stronger than binding of SopE2 to Rac1. 2) SopE2-mediated in vitro guanine nucleotide exchange is ~10-fold more efficient for Cdc42 than for Rac1. 3) Affinity precipitation assays revealed that, upon translocation into COS7 tissue culture cells, SopE2 activates Cdc42, but essentially no Rac1. 4) Translocation of SopE2 into HUVEC tissue culture cells induces actin cytoskeletal rearrangements characteristic for specific activation of Cdc42. In contrast, SopE interacted efficiently with both Cdc42 and Rac1 in vitro and in vivo. Analysis of a SopE-SopE2 chimeric protein (promoter region and aa 1-95 of SopE (= translocation signal) fused to aa 96-240 of SopE2 (= catalytic domain)) verified that the observed specificities in vivo are really attributable to the catalytic C-terminal domains (data not shown). Altogether, SopE and SopE2 provide S. typhimurium with a means to specifically activate either Cdc42 and Rac1 or Cdc42 but not Rac1.

Eukaryotic GEFs share a common functional unit (DH plus PH domain), which facilitates GTPase binding and catalysis. Yet, the eukaryotic GEFs for RhoGTPases display different specificities for different subsets of RhoGTPases (5, 42). The three-dimensional structure of Rac1 complexed with the DH and PH domains of the eukaryotic GEF Tiam1 has identified the amino acid residues determining the binding specificity (43). Unfortunately, as SopE and SopE2 do not share any recognizable sequence similarity with eukaryotic GEFs, it is impossible to predict the amino acid residues responsible for the different substrate preferences of SopE and SopE2 from the data of Worthylake et al. (43).

Do all Salmonella strains address Cdc42 and Rac1? Phylogenetic analyses have shown that sopE2 is present in all contemporary Salmonella lineages (21, 22, 26). Therefore, the capacity to directly activate Cdc42 but not Rac1 (via SopE2) inside cells of the animal host is common to all Salmonellae. In contrast, sopE is encoded in the genome of a bacteriophage, which is only present in very few Salmonella strains, including the S. typhimurium strain SL1344 used in this study (26, 27, 44, 45). A second S. typhimurium strain (ATCC 14028) that is commonly used to study virulence mechanisms does not carry SopEPhi and does not express SopE.2 Therefore, the capacity to directly activate Rac1 signaling (via SopE) is not strictly required for Salmonella virulence per se. However, it is certainly possible that SopE2 can activate Rac1 via an indirect mechanism, as it is known that specific activation of Cdc42 will finally result in activation Rac1 in Swiss 3T3 fibroblasts (11).

Nonetheless, expression of SopE improves virulence. Interestingly, SopE-expressing S. typhimurium strains are associated with severe epidemics (44). It has been speculated that the improved epidemic virulence of these strains might simply be attributable to a higher "sopE" gene dosage and higher total amounts of SopE-like proteins delivered into host cells (44). However, the data presented here suggest that the improved virulence of sopE-positive S. typhimurium strains is much rather linked to the capacity of these strains to directly activate Rac1 and Cdc42 (via SopE) inside host cells.

Indeed, there are several lines of evidence from tissue culture experiments suggesting that direct activation of Cdc42 and Rac1 are needed to optimize host cell invasion. 1) Disruption of the sopE gene in S. typhimurium strain SL1344 leads to a 2-fold decreased invasiveness into COS7 tissue culture cells (27), whereas a sopE2 mutant is equally invasive as the wild-type SL1344 strain (22). This argues that the presence of SopE can fully compensate for the loss of SopE2, whereas SopE2 (possibly due to its inability to directly activate Rac1) cannot completely compensate for the loss of SopE. 2) Complementation of a non-invasive S. typhimurium strain (M516 = SL1344, sopE-, sopE2-, sopB-), which lacks all three translocated effector proteins triggering bacterial entry with a SopE expression vector, is 2-fold more efficient than complementation with a SopE2 expression vector (26). 3) Disruption of Cdc42 signaling inside COS7 cells by transfection with Cdc42N17 expression vectors is 2-fold more efficient at blocking S. typhimurium SL1344 invasion than disruption of Rac1 signaling via Rac1N17 (23). In conclusion, these observations suggest that the capacity to directly activate Rac1 (in addition to Cdc42) via SopE improves S. typhimurium virulence.

Taken together, our results show for the first time that S. typhimurium can specifically activate different RhoGTPases of the host cell via the translocated effector proteins SopE and SopE2. This allows the bacteria to fine tune host cellular responses very precisely. Future work must address how SopE/SopE2-triggered signaling may be further modulated by the other translocated effector proteins like the actin-binding protein SipA (19), the phosphatidyl inositol phosphatase SopB (31), or the GTPase-activating protein SptP (46). This will further advance our current knowledge of the intricate network of responses triggered by the translocated effector proteins of S. typhimurium in order to alter host cell signaling in a very precise manner.

    ACKNOWLEDGEMENT

We thank Dr. Irmgard Assfalg-Machleidt for helpful instructions for performance and evaluation of surface plasmon resonance measurements on the BIAcore 2000 instrument.

    FOOTNOTES

* This work was supported by grants from the Deutsche Forschungsgemeinschaft (Nachwuchsgruppe of W.-D. Hardt; BIAcore 2000-work Sonderforschungsbereich 469 of the Ludwig Maximilians Universität München, Grant A-6/Machleidt).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 49-89-5160-5263; Fax: 49-89-5160-5223; E-mail: hardt@m3401.mpk.med.uni-muenchen.de.

Published, JBC Papers in Press, July 5, 2001, DOI 10.1074/jbc.M100609200

2 S. Mirold and W.-D. Hardt, unpublished data.

    ABBREVIATIONS

The abbreviations used are: GEF, guanine nucleotide exchange factor; aa, amino acid(s); mGDP, O-(N-methylanthraniloyl)-GDP; GST, glutathione S-transferase; HUVEC, human umbilical vein endothelial cell; CD, Cdc42/Rac1-binding domain; PH, pleckstrin homology; DH, Dbl homology; PAK, p21-activated kinase; DTT, dithiothreitol; PBS, phosphate-buffered saline; BSA, bovine serum albumin; SPI1, Salmonella pathogenicity island I.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Ridley, A. J. (2000) in GTPases (Hall, A., ed) , pp. 89-136, Oxford University Press, Oxford
2. Bourne, H. R., Sanders, D. A., and McCormick, F. (1991) Nature 349, 117-127
3. Boguski, M. S., and McCormick, F. (1993) Nature 366, 643-654
4. Bishop, A. L., and Hall, A. (2000) Biochem. J. 348, 241-255
5. Cerione, R. A., and Zheng, Y. (1996) Curr. Opin. Cell Biol. 8, 216-222
6. Hall, A. (1998) Science 279, 509-514
7. Van Aelst, L., and D'Souza-Schorey, C. (1997) Genes Dev. 11, 2295-2322
8. Ridley, A. J., and Hall, A. (1992) Cell 70, 389-399
9. Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., and Hall, A. (1992) Cell 70, 401-410
10. Kozma, R., Ahmed, S., Best, A., and Lim, L. (1995) Mol. Cell. Biol. 15, 1942-1952
11. Nobes, C. D., and Hall, A. (1995) Cell 81, 53-62
12. Galán, J. E. (1999) Curr. Opin. Microbiol. 2, 46-50
13. Wood, M. W., Rosqvist, R., Mullan, P. B., Edwards, M. H., and Galyov, E. E. (1996) Mol. Microbiol. 22, 327-338
14. Galyov, E. E., Wood, M. W., Rosqvist, R., Mullan, P. B., Watson, P. R., Hedges, S., and Wallis, T. S. (1997) Mol. Microbiol. 25, 903-912
15. Collazo, C. M., and Galán, J. E. (1997) Mol. Microbiol. 24, 747-756
16. Hardt, W.-D., and Galán, J. E. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 9887-9892
17. Jones, M. A., Wood, M. W., Mullan, P. B., Watson, R., Wallis, T. J., and Galyov, E. E. (1998) Infect. Immun. 66, 5799-5804
18. Fu, Y., and Galán, J. E. (1998) Mol. Microbiol. 27, 359-368
19. Zhou, D., Mooseker, M. S., and Galán, J. E. (1999) Science 283, 2092-2095
20. Miao, E. A., Scherer, C. A., Tsolis, R. M., Kingsley, R. A., Adams, L. G., Bäumler, A. J., and Miller, S. I. (1999) Mol. Microbiol. 34, 850-864
21. Bakshi, C. S., Singh, V. P., Wood, M. W., Jones, P. W., Wallis, T. S., and Galyov, E. E. (2000) J. Bacteriol. 182, 2341-2344
22. Stender, S., Friebel, A., Linder, S., Rohde, M., Mirold, S., and Hardt, W.-D. (2000) Mol. Microbiol. 36, 1206-1221
23. Chen, L. M., Hobie, S., and Galán, J. E. (1996) Science 274, 2115-2118
24. Hardt, W.-D., Chen, L. M., Schuebel, K. E., Bustelo, X. R., and Galán, J. E. (1998) Cell 93, 815-826
25. Chen, L. M., Bagrodia, S., Cerione, R. A., and Galán, J. E. (1999) J. Exp. Med. 189, 1479-1488
26. Mirold, S., Ehrbar, K., Weissmüller, A., Prager, R., Tschäpe, H., Rüssmann, H., and Hardt, W.-D. (2001) J. Bacteriol. 183, 2348-2358
27. Hardt, W.-D., Urlaub, H., and Galán, J E. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 2574-2579
28. Hong, K. H., and Miller, V. L. (1998) J. Bacteriol. 180, 1793-1802
29. Galán, J. E., and Zhou, D. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 8754-8761
30. Zhou, D., Chen, L. M., Hernandez, L., Shears, S. B., and Galán, J. E. (2001) Mol. Microbiol. 39, 248-259
31. Norris, F. A., Wilson, M. P., Wallis, T. S., Galyov, E. E., and Majerus, P. W. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 14057-14059
32. Rudolph, M. G., Weise, C., Mirold, S., Hillenbrand, B., Bader, B., Wittinghofer, A., and Hardt, W.-D. (1999) J. Biol. Chem. 274, 30501-30509
33. Hoiseth, S. K., and Stocker, B. A. (1981) Nature 291, 238-239
34. Friebel, A., and Hardt, W. D. (2000) Methods Enzymol. 325, 82-91
35. Sander, E. E., van Delft, S., ten Klooster, J. P., Reid, T., van der Kammen, R. A., Michiels, F., and Collard, J. G. (1998) J. Cell Biol. 143, 1385-1398
36. Obert, S., O'Connor, R. J., Schmid, S., and Hearing, P. (1994) Mol. Cell. Biol. 2, 1333-1346
37. Aepfelbacher, M., Essler, M., Huber, E., Sugai, M., and Weber, P. C. (1997) Arterioscler. Thromb. Vasc. Biol. 17, 1623-1629
38. Leonard, D. A., Evans, T., Hart, M., Cerione, R. A., and Manor, D. (1994) Biochemistry 33, 12323-12328
39. Rudolph, M. G., Bayer, P., Abo, A., Kuhlmann, J., Vetter, I. R., and Wittinghofer, A. (1998) J. Biol. Chem. 273, 18067-18076
40. Azim, A. C., Barkalow, K. L., and Hartwig, J. H. (2000) Methods Enzymol. 325, 257-263
41. Andor, A., Trülzsch, K., Essler, M., Roggenkamp, A., Wiedemann, A., Heesemann, J., and Aepfelbacher, M. (2001) Cell. Microbiol. 3, 301-310
42. Stam, J. C., and Collard, J. G. (1999) Prog. Mol. Subcell. Biol. 22, 51-83
43. Worthylake, D. K., Rossman, K. L., and Sondek, J. (2000) Nature 408, 682-688
44. Mirold, S., Rabsch, W., Rohde, M., Stender, S., Tschäpe, H., Rüssmann, H., Igwe, E., and Hardt, W.-D. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 9845-9850
45. Prager, R., Mirold, S., Tietze, E., Strutz, U., Knüppel, B., Rabsch, W., Hardt, W.-D., and Tschäpe, H. (2000) Int. J. Med. Microbiol. 290, 605-617
46. Fu, Y., and Galán, J. E. (1999) Nature 401, 293-297


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Infect. Immun.Home page
K. R. Buchholz and R. S. Stephens
The Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway Induces the Inflammatory Factor Interleukin-8 following Chlamydia trachomatis Infection
Infect. Immun., December 1, 2007; 75(12): 5924 - 5929.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Brown, L. Bry, Z. Li, and D. B. Sacks
IQGAP1 Regulates Salmonella Invasion through Interactions with Actin, Rac1, and Cdc42
J. Biol. Chem., October 12, 2007; 282(41): 30265 - 30272.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
E. C. Boyle, N. F. Brown, J. H. Brumell, and B. B. Finlay
Src homology domain 2 adaptors affect adherence of Salmonella enterica serovar Typhimurium to non-phagocytic cells
Microbiology, October 1, 2007; 153(10): 3517 - 3526.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
I. M. V. Thijs, S. C. J. De Keersmaecker, A. Fadda, K. Engelen, H. Zhao, M. McClelland, K. Marchal, and J. Vanderleyden
Delineation of the Salmonella enterica Serovar Typhimurium HilA Regulon through Genome-Wide Location and Transcript Analysis
J. Bacteriol., July 1, 2007; 189(13): 4587 - 4596.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
J. C. Patel and J. E. Galan
Differential activation and function of Rho GTPases during Salmonella-host cell interactions
J. Cell Biol., November 6, 2006; 175(3): 453 - 463.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
N. F. Brown, J. Szeto, X. Jiang, B. K. Coombes, B. B. Finlay, and J. H. Brumell
Mutational analysis of Salmonella translocated effector members SifA and SopD2 reveals domains implicated in translocation, subcellular localization and function.
Microbiology, August 1, 2006; 152(Pt 8): 2323 - 2343.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S.-Y. Jiang and S. Ramachandran
Comparative and evolutionary analysis of genes encoding small GTPases and their activating proteins in eukaryotic genomes
Physiol Genomics, February 23, 2006; 24(3): 235 - 251.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. E. Balana, F. Niedergang, A. Subtil, A. Alcover, P. Chavrier, and A. Dautry-Varsat
ARF6 GTPase controls bacterial invasion by actin remodelling
J. Cell Sci., May 15, 2005; 118(10): 2201 - 2210.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. Panthel, K. M. Meinel, V. E. S. Domenech, H. Retzbach, E. I. Igwe, W.-D. Hardt, and H. Russmann
Salmonella Pathogenicity Island 2-Mediated Overexpression of Chimeric SspH2 Proteins for Simultaneous Induction of Antigen-Specific CD4 and CD8 T Cells
Infect. Immun., January 1, 2005; 73(1): 334 - 341.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
F.-C. Huang, A. Werne, Q. Li, E. E. Galyov, W. A. Walker, and B. J. Cherayil
Cooperative Interactions between Flagellin and SopE2 in the Epithelial Interleukin-8 Response to Salmonella enterica Serovar Typhimurium Infection
Infect. Immun., September 1, 2004; 72(9): 5052 - 5062.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. Drecktrah, L. A. Knodler, and O. Steele-Mortimer
Modulation and Utilization of Host Cell Phosphoinositides by Salmonella spp.
Infect. Immun., August 1, 2004; 72(8): 4331 - 4335.
[Full Text] [PDF]


Home page
J. Bacteriol.Home page
S. M. Bueno, C. A. Santiviago, A. A. Murillo, J. A. Fuentes, A. N. Trombert, P. I. Rodas, P. Youderian, and G. C. Mora
Precise Excision of the Large Pathogenicity Island, SPI7, in Salmonella enterica Serovar Typhi
J. Bacteriol., May 15, 2004; 186(10): 3202 - 3213.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Hapfelmeier, K. Ehrbar, B. Stecher, M. Barthel, M. Kremer, and W.-D. Hardt
Role of the Salmonella Pathogenicity Island 1 Effector Proteins SipA, SopB, SopE, and SopE2 in Salmonella enterica Subspecies 1 Serovar Typhimurium Colitis in Streptomycin-Pretreated Mice
Infect. Immun., February 1, 2004; 72(2): 795 - 809.